首页> 外文OA文献 >A Novel Therapy for Sickle Cell Disease (SCD): Co-Transplantation of Nicord® Ex Vivo Expanded Umbilical Cord Blood (UCB) Progenitor Cells with Nicotinamide and an Unmanipulated Unrelated UCB Graft Leads to Successful Engraftment and Cure of Severe SCD

【2h】

A Novel Therapy for Sickle Cell Disease (SCD): Co-Transplantation of Nicord® Ex Vivo Expanded Umbilical Cord Blood (UCB) Progenitor Cells with Nicotinamide and an Unmanipulated Unrelated UCB Graft Leads to Successful Engraftment and Cure of Severe SCD

机译：镰状细胞疾病（SCD）的新疗法：Nicord®离体扩增的脐带血（UCB）祖细胞与烟酰胺的祖细胞的共移植，并且不合格的无关的UCB移植物导致严重SCD的成功植入和治愈

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Suhag Parikh; Joel A. Brochstein; Stephen Wease; Paul L. Martin; Mitchell E. Horwitz; Aurelie Schwarzbach; Joanne Kurtzberg;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. A Novel Therapy for Sickle Cell Disease (SCD): Co-Transplantation of Nicord? [Ex Vivo Expanded Umbilical Cord Blood (UCB) Progenitor Cells with Nicotinamide] and an Unmanipulated Unrelated UCB Graft Leads to Successful Engraftment and Cure of Severe SCD [J] . Suhag Parikh, Joel A. Brochstein, Stephen Wease, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2018,第3期

机译：镰状细胞疾病（SCD）的新疗法：尼古德的共同移植？ [exVivo扩增脐带血（UCB）祖细胞与烟酰胺]和非规划的不相关的UCB移植物导致成功的植入和严重SCD的固化
2. A Novel Therapy for Sickle Cell Disease (SCD): Co-Transplantation of Nicord? [Ex Vivo Expanded Umbilical Cord Blood (UCB) Progenitor Cells with Nicotinamide] and an Unmanipulated Unrelated UCB Graft Leads to Successful Engraftment and Cure of Severe SCD [J] . Suhag Parikh, Joel A. Brochstein, Stephen Wease, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2018,第3期

机译：None
3. Successful Engraftment of Donor Umbilical Cord Blood (UCB) Cells after Co-Transplantation of Nicord (R) (Ex Vivo Expanded UCB Progenitor Cells with Nicotinamide) and a Second Unmanipulated Cord Blood Unit after Myeloablative Chemotherapy in Pediatric Patients with Severe Sickle Cell Disease [J] . Parikh Suhag H., Brochstein Joel, Martin Paul L., Blood: The Journal of the American Society of Hematology . 2016,第22期

机译：在患有少亮罗胺蛋白质（r）（离体扩增的UCB祖细胞）和霉菌化疗后的霉菌化疗后的第二个Unmaniputed脐带血单位后成功植入供体脐脐血（UCB）细胞的植入细胞
4. Enhancing engraftment of cord blood cells via insight into the biology of stem/progenitor cell function [C] . Hal E. Broxmeyer International Conference and Workshop on Hematopoietic Stem Cells . 2012

机译：通过洞察茎/祖细胞功能的洞察力增强脐带血细胞的植入
5. Umbilical cord blood derived endothelial progenitor cells: Isolation, characterization, and adhesion potential in vitro and in vivo. [D] . Brown, Melissa Ann. 2009

机译：脐带血来源的内皮祖细胞：体外和体内的分离，鉴定和粘附潜力。
6. Mouse fetal and embryonic liver cells differentiate human umbilical cord blood (UCB) progenitors into CD56 negative NK cell precursors in the absence of IL-15 [O] . Valarie McCullar, Robert Oostendorp, Angela Panoskaltsis-Mortari, -1

机译：在没有IL-15的情况下小鼠胎儿和胚胎肝细胞将人脐带血（UCB）祖细胞分化为CD56阴性NK细胞前体
7. Nicord® Expanded Hematopoietic Progenitor Cells (HPC) Are Capable of Outcompeting the Unmanipulated (UM) Cord Blood Unit and of Prolonged Myeloid and Lymphoid Engraftment Following Myeloablative Dual Umbilical Cord Blood (UCB) Transplantation [O] . Horwitz Mitchell E., Stiff Patrick J., Chao Nelson J., 2013

机译：Nicord®扩增的造血祖细胞（HPC）能够胜过清髓性双脐带血（UCB）移植后未操纵的（UM）脐血单元的竞争以及长期的骨髓和淋巴样移植。

A Novel Therapy for Sickle Cell Disease (SCD): Co-Transplantation of Nicord® Ex Vivo Expanded Umbilical Cord Blood (UCB) Progenitor Cells with Nicotinamide and an Unmanipulated Unrelated UCB Graft Leads to Successful Engraftment and Cure of Severe SCD

著录项

相似文献

相关主题

期刊订阅